mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors

被引：2
作者：
Yekeduz, Emre [1 ,2 ]
Ayasun, Ruveyda [2 ,3 ]
Koksoy, Elif Berna [1 ,2 ]
Utkan, Gungor [1 ,2 ]
Urun, Yuksel [1 ,2 ]
Akbulut, Hakan [1 ,2 ]
机构：
[1] Ankara Univ, Dept Med Oncol, Ankara, Turkey
[2] Ankara Univ, Canc Res Inst, Ankara, Turkey
[3] Hacettepe Univ, Dept Med Oncol, Canc Inst, Ankara, Turkey
来源：
FUTURE VIROLOGY | 2021年 / 16卷 / 09期
关键词：
cancer; COVID-19; immunotherapy; mRNA; SARS-CoV-2; vaccine; INFLUENZA VACCINATION; SAFETY; IMMUNOGENICITY;
D O I：
10.2217/fvl-2021-0166
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：583 / 585
页数：3
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors in cancer patients with COVID-19
    Pan, Yun
    Tan, Jiaxiong
    Li, Jinzhong
    Li, Taoyuan
    Li, Jieying
    Cao, Yang
    Yang, Liu
    Lin, Xunge
    Li, Minran
    Liang, Xujing
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [2] Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
    Gilbert, Danielle
    Hu, Junxiao
    Medina, Theresa
    Kessler, Elizabeth R.
    Lam, Elaine T.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [3] COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis
    Ruiz, Juan Ignacio
    Lopez-Olivo, Maria Angeles
    Geng, Yimin
    Suarez-Almazor, Maria E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (02)
  • [4] COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review
    Ruiz, Juan I.
    Lopez-Olivo, Maria A.
    Geng, Yimin
    Suarez-Almazor, Maria E.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2023, 6 (02) : 103 - 110
  • [5] COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint Inhibitors
    Mengni Guo
    Jieying Liu
    Shuntai Zhou
    James Yu
    Zohaib Ahmed
    Sarfraz Ahmad
    Manoucher Manoucheri
    Mark A. Socinski
    Tarek Mekhail
    Vincent Hsu
    SN Comprehensive Clinical Medicine, 4 (1)
  • [6] Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review)
    Vivarelli, Silvia
    Falzone, Luca
    Torino, Francesco
    Scandurra, Giuseppa
    Russo, Giulia
    Bordonaro, Roberto
    Pappalardo, Francesco
    Spandidos, Demetrios A.
    Raciti, Giuseppina
    Libra, Massimo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 58 (02) : 145 - 157
  • [7] Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer
    Tan, Ruoding
    Yun, Cindy
    Seetasith, Arpamas
    Sheinson, Daniel
    Walls, Robert
    Ngwa, Innocent
    Reddy, Josina C.
    Zhang, Qing
    Secrest, Matthew H.
    Lambert, Peter
    Sarsour, Khaled
    ONCOLOGIST, 2022, 27 (03) : 236 - 243
  • [8] A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Guo, Mengni
    Liu, Jieying
    Miao, Ruoyu
    Ahmed, Zohaib
    Yu, James
    Guan, Jian
    Ahmad, Sarfraz
    Zhou, Shuntai
    Grove, Angela
    Manoucheri, Manoucher
    Socinski, Mark A.
    Mekhail, Tarek
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (09) : 389 - 395
  • [9] Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia
    Mori, Akio
    Onozawa, Masahiro
    Kobayashi, Mirei
    Tsukamoto, Shihori
    Senjo, Hajime
    Ishio, Takashi
    Yokoyama, Emi
    Izumiyama, Koh
    Saito, Makoto
    Muraki, Haruna
    Morioka, Masanobu
    Teshima, Takanori
    Kondo, Takeshi
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (06) : 717 - 721
  • [10] Vaccines against COVID-19: Priority to mRNA-Based Formulations
    Pascolo, Steve
    CELLS, 2021, 10 (10)
12345